Hopp til hovedinnhold

Kreft i munnhulen

Sist oppdatert: Sist revidert:
Sist revidert av:


Definisjon:
Neoplasmer som befinner seg i området fra leppene og til overgangen mellom den bløte og harde gane
Forekomst:
Insidensrater i 2019 var menn 15,6/100.000 og kvinner 7,7/100.000
Symptomer:
Tilstanden debuterer som regel med et smertefritt sår eller en "flekk" på leppen eller i munnhulen
Funn:
I tidlig fase er ikke-tilhelende sår eller som en rød eller hvit flekk
Diagnostikk:
Tilleggsundersøkelser er biopsi, CT og/eller MR
Behandling:
Kirurgi. Strålebehandling og kjemoterapi er ofte adjuvant behandling
  1. Poon CS, Stenson KM. Overview of the diagnosis and staging of head and neck cancer. UpToDate, last updated Apr 02, 2021. www.uptodate.com  
  2. Kreftregisteret. Cancer in Norway 2019. Oslo: 2020, www.kreftregisteret.no.
  3. Pakkeforløp for hode-halskreft. Helsedirektoratet 2015
  4. Machado J, Reis PP, Zhang T, et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2010; 2: 6. PubMed  
  5. Angiero F, Gatta LB, Seramondi R, et al. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res 2010; 30: 3435-40. PubMed  
  6. Mehta V, Yu GP, Schantz SP. Population-based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope. 2010 Aug 3. Epub ahead of print.
  7. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2008; Sep 17.
  8. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl. 2005;(179):1-66.
  9. Rennemo E, Zätterström U, Boysen M. Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy. Laryngoscope 2011; 121:304. PubMed  
  10. Edge, SB, Byrd, DR, Compton, CC, et al (Eds). AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th ed, Springer, New York, 2010.
  11. Brockstein BE, Stenson KM, Song S. Overview of treatment for head and neck cancer. UpToDate, last updated Jan 15, 2021. UpToDate  
  12. Nguyen NP, Almeida F. Oropharyngeal cancer. BMJ Best Practice, last updated 03 Sep 2020. bestpractice.bmj.com  
  13. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 819-21. PubMed  
  14. Cramer JD, Grauer J, Sukari A et al. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021 Oct 28. Epub ahead of print. PMID: 34709369.
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Olbjørn Klepp, professor dr.med, Norges teknisk-naturvitenskapelige universitet og overlege Kreftavd. Regionsykehuset i Trondheim
  • Stein Helge Glad Nordahl, øre-nese-hals spesialist, overlege Haukeland sykehus, Bergen